Diabetes, An Issue of Endocrinology and Metabolism Clinics of North America

Name: Diabetes, An Issue of Endocrinology and Metabolism Clinics of North America
Brand: Elsevier
Price: 103.52 EUR
Availability: OnlineOnly

S. Sethu K. Reddy(Autor*in)

Elsevier (Verlag)

1. Auflage

Erschienen am 9. November 2016

100 Seiten

E-Book

ePUB mit Adobe-DRM

Systemvoraussetzungen

978-0-323-47759-8 (ISBN)

103,52 €inkl. 7% MwSt.

Systemvoraussetzungen

für ePUB mit Adobe-DRM

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

Weitere Details

Weitere Ausgaben

Inhalt

Intro
Title page
Table of Contents
Copyright
Contributors
Forthcoming Issues
Foreword
Preface
Prediabetes: A Worldwide Epidemic
Key points
Definition and the diagnosis of prediabetes
Epidemiology
Pathogenesis of prediabetes
The relationship between metabolic syndrome, insulin resistance, and prediabetes
Complications of prediabetes
Treatment of prediabetes and the prevention of type 2 diabetes and its complications
The future
Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus
Key points
Introduction
Epidemiology
Pathophysiology
Metabolic and cardiovascular implications
Diagnosis
Treatment
Summary
Lipodystrophy Syndromes
Key points
Introduction
Genetic lipodystrophies
Acquired lipodystrophies
Management
Nutrition in Diabetes
Key points
Introduction
Medical nutrition therapy for diabetes management
Specific nutrition plans for patients with diabetes
Future consideration
Metformin: From Research to Clinical Practice
Key points
Introduction
Use in type 2 diabetes mellitus
Use in other diseases and conditions
Current research on possible new uses for metformin
Summary
Insulin: Making Sense of Current Options
Key points
The history and evolution of insulin
Basal insulins
Insulin glargine 300 U/mL (Toujeo)
Follow-on biologic insulin glargine (Basaglar)
Insulin degludec (Tresiba, insulin degludec U-100, insulin degludec U-200, Ryzodeg-insulin degludec/insulin aspart 100 U/mL)
Prandial insulins
Insulin lispro 200 U/mL (lispro U-200, Humalog)
Insulin human inhalation power (technosphere insulin, Afrezza)
Summary
Inpatient Diabetes Management in the Twenty-First Century
Key points
Rationale
Glucose targets in noncritically ill patients
Diabetes management for noncritically ill hospitalized patients
Insulin pump management in the hospital
Perioperative diabetes management
Hyperglycemia management of critically ill inpatients
Hypoglycemia
Summary
Utility of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes
Key points
Introduction
Continuous glucose monitoring technology
Use of continuous glucose monitoring in Type 1 diabetes mellitus
Continuous glucose monitoring in type 2 diabetes mellitus
The future
Summary
Bariatric Surgery: Pathophysiology and Outcomes
Key points
Background
Obesity and type 2 diabetes
Effects of weight loss
Restrictive and malabsorptive bariatric surgery procedures
Mechanisms for diabetes remission
Metabolic effects of bariatric surgery and outcomes
Bariatric surgery and macrovascular complications of diabetes
Bariatric surgery and microvascular complications of diabetes
Bariatric surgery-associated adverse events and complications
Summary
Islet Cell Transplantation and Alternative Therapies
Key points
Pancreas versus islet for endocrine therapy
Immunosuppression and new developing strategies
Islet encapsulation
Summary
Understanding Population Health Through Diabetes Population Management
Key points
Introduction
Diabetes, a chronic disease
Population management
The challenges with measuring population health
Role of information technology
Population health and diabetes
Chronic care delivery
Improving quality through population health
Summary
Evidence-based Mobile Medical Applications in Diabetes
Key points
Background
Brief overview of products
Discussion
Transcultural Endocrinology: Adapting Type-2 Diabetes Guidelines on a Global Scale
Key points
Introduction
Why transculturalize: the global dimension of type 2 diabetes care
How to transculturalize: general process and recommendations
Adapting evidence-based interventions to prevent and treat diabetes
Future directions
Evolving to Personalized Medicine for Type 2 Diabetes
Key points
Type 2 diabetes mellitus
Secondary diabetes mellitus and diabetes due to pancreatic destruction
Costs of diabetes mellitus: morbidity
Summary
Index

Systemvoraussetzungen

Als PDF speichern Als Link merken